Kuldeep Bhatia


The use of disease-modifying anti-rheumatic drugs for the management of rheumatoid arthritis

Two different types of disease-modifying anti-rheumatic drugs (DMARDs) are used for the management of rheumatoid arthritis. These are referred to as conventional DMARDs and biologic DMARDs (bDMARDs). Since the introduction of bDMARDs in 2003, the government subsidy for DMARDs has increased markedly. This report examines...

Juvenile arthritis in Australia

Juvenile arthritis is one of the common chronic diseases affecting Australian children. The disease contributes significantly to ill health, affecting growth and skeletal maturity of children. The life course of the disease entails a variety of complications, activity limitations and need for regular support and...

Impairments and disability associated with arthritis and osteoporosis

Arthritis and osteoporosis are major sources of pain, activity limitations and functional restrictions, in particular among older Australians. At an individual level and for their carers, the experience of these diseases and conditions is catastrophic overshadowing daily activities. Regional musculoskeletal limitations not only threaten autonomy...

Arthritis and musculoskeletal conditions in Australia, 2005

Arthritis and musculoskeletal conditions are large contributors to illness, pain and disability in Australia. More than 6.1 million Australians are reported to have arthritis or a musculoskeletal condition. Most commonly reported conditions are back pain and various forms of arthritis. Almost 1.2 million of these...